The mission of the Duke Division of Hematologic Malignancies and Cellular Therapy is to promote health and improve lives by preventing, diagnosing, and treating blood cancer and other life threatening diseases through integrated, innovative, and holistic patient care, education, and research.

Excellence in Patient Care

Our faculty provide comprehensive, multidisciplinary care for patients with hematologic malignancies at the Duke Cancer Center and the Duke Adult Blood & Marrow Transplant Clinic.

Learn more

Excellence in Research

The Duke Hematologic Malignancies and Cellular Therapy (HMCT) Program is a multidisciplinary basic, translational, and clinical research program whose overall goal is to improve outcomes for patients with hematologic malignancies. 

Learn more

Train with us

The Hematology-Oncology Fellowship program provides clinical and laboratory training in hematology, medical oncology, and bone marrow transplantation.

Learn more

Latest News

News
Tuesday, September 14, 2021
News
Thursday, August 12, 2021
News
Tuesday, July 27, 2021
News
Monday, July 26, 2021
News
Wednesday, June 9, 2021
News
Wednesday, June 9, 2021

Upcoming Events

Event
 - Hematologic Malignancies and Cellular Therapy

HM Grand Rounds

October 1, 2021 - 8:30am
Dr. Mitchell Horwitz
Event
 - Hematologic Malignancies and Cellular Therapy

HM Grand Rounds

October 8, 2021 - 8:30am
Dr. Yubin Kang
Event
 - Hematologic Malignancies and Cellular Therapy

HM Grand Rounds

October 15, 2021 - 8:30am
Dr. Heather Wolfe
Event
 - Hematologic Malignancies and Cellular Therapy

HM Grand Rounds

October 22, 2021 - 8:30am
Myeloma APP
Event
 - Hematologic Malignancies and Cellular Therapy

HM Grand Rounds

November 5, 2021 - 8:30am
Dr. Richard Lopez